Similar Papers

Paper Title
Journal
Date
Author
How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study
Joel Lexchin
Healthcare Policy | Politiques de Santé | VOL. 12
Joel LexchinJoel Lexchin
30 Nov 2016
Formulary status of drugs in Ontario after Health Canada has issued a serious safety warning: a cohort study.
Joel Lexchin
International Journal of Risk & Safety in Medicine | VOL. 27
Joel LexchinJoel Lexchin
15 Sep 2015
New drug submissions in Canada and a comparison with the Food and Drug Administration and the European Medicines Agency: Cross-sectional analysis.
Joel Lexchin
PloS one | VOL. 18
Joel LexchinJoel Lexchin
15 Jun 2023
Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy.
Joel Lexchin
British journal of clinical pharmacology | VOL. 79
Joel LexchinJoel Lexchin
22 Apr 2015
View more papers

More From: BMJ Open

Paper Title
Journal
Date
Author
How do multiple deprivations in nuanced urban and rural settings affect health differently in South Africa? Evidence from NIDS data, 2017
Msawenkosi Dlamini ... Josue Mbonigaba
BMJ Open | VOL. 15
Msawenkosi Dlamini, et. al.Msawenkosi Dlamini ... Josue Mbonigaba
29 Jan 2025
Barriers and facilitators to improved sedentary behaviour in coronary heart disease patients: a scoping review
Yuting Yang ... Lili Yang
BMJ Open | VOL. 15
Yuting Yang, et. al.Yuting Yang ... Lili Yang
29 Jan 2025
Assessing the feasibility of measuring residents’ quality of life in English care homes and the construct validity and internal consistency of measures completed by staff proxy: a cross-sectional study
Ann-Marie Towers ... Claire Goodman
BMJ Open | VOL. 15
Ann-Marie Towers, et. al.Ann-Marie Towers ... Claire Goodman
29 Jan 2025
Qualitative evaluation of the Rehabilitation Exercise and psycholoGical support After COVID-19 InfectioN (REGAIN) randomised controlled trial (RCT): ‘you are not alone’
Kate Seers ... Gordon Mcgregor
BMJ Open | VOL. 15
Kate Seers, et. al.Kate Seers ... Gordon Mcgregor
29 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.